Physician profile
Mark W Wright
NPI 1821098732
$698.64
in general payments reported to CMS, 2019-2025
12 companies · $146 in 2025
The $146 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $28.28 · 2020: $14.13 · 2021: $80.04 · 2022: $79.46 · 2023: $215 · 2024: $136 · 2025: $146.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $497.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $496.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shockwave Medical, INC | $129.93 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Stryker Corporation | $91.94 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Corium, LLC | $88.94 | 2022-2024 | Azstarys |
| Inari Medical, INC. | $84.90 | 2024-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Genentech USA, INC. | $83.04 | 2019-2022 | |
| Pfizer INC. | $63.25 | 2019-2024 | |
| Glaxosmithkline, LLC. | $55.32 | 2021-2023 | Bexsero |
| Nestle Healthcare Nutrition INC. | $32.23 | 2023 | |
| Tris Pharma INC | $21.28 | 2022 | |
| Merck Sharp & Dohme LLC | $19.76 | 2023 | M-M-R II, Vaxelis, Vaxneuvance |
| Tactile Systems Technology INC | $14.54 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $13.51 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Wright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.